If you need more lookups,
subscriptions start at $34 USD/month.
Mark Curtis Work
2026 -now Director, Strategic Partnerships and Licensing @
2025 -2026 Business Development and Commercial Director, CDMO, Rose BioSolutions @
2023 -2025 CEO @
2021 -2023 Director, CMC, Gene Therapy @
2020 -2021 Director, Manufacturing Partnerships @
2017 -2019 Associate Director, Business Development, Cell and Gene Therapy @
2016 -2017 Portfolio Manager, Cell and Gene Therapy @
2013 -2016 Analyst, Business Development @
2010 -2012 Scientific Diligence Analyst @
2009 -2010 Research Technician - Ontario Cancer Institute @
2025 -now Business Development and Commercial Director, CDMO, Charles River @
Mark Curtis Education
UNSW
MSc (Biotechnology)
2008-2009
Queen's University
BSc (Hon) (Biology)
2003-2007
Mark Curtis Skills
Business Development
Research
Biotechnology
Market Research
Capital Markets
Lifesciences
Financial Modeling
Equities
Venture Capital
Commercialization
Business Strategy
Strategic Planning
Valuation
Analysis
Equity Research
Due Diligence
Cell
Start-ups
Life Sciences
Leadership
Public Speaking
Start Ups
Customer Service
Cell Biology
Strategy
Molecular Biology
Pharmaceutical Industry
Mark Curtis Summary
Mark Curtis, is currently a Director, Strategic Partnerships and Licensing at Minaris Advanced Therapies. Mark Curtis brings experience from previous roles at Rose BioSolutions, LineaBio and AVROBIO. Mark Curtis holds a 2008 - 2009 MSc in Biotechnology @ UNSW. With a robust skill set that includes Business Development, Research, Biotechnology, Market Research, Capital Markets and more. Mark Curtis has 5 emails on RocketReach.
Looking for a different Mark Curtis?
Find contact details for 700 million professionals.